Photo: Tom Williams/CQ-Roll Call, Inc via Getty Imag In a major blow to national vaccination efforts, the FDA and CDC recommended suspending the use of Johnson & Johnson's one-shot COVID vaccine because at least six people had developed severe blood clots after receiving it. The affected vaccine recipients were all between the ages of 18 and 48, with the clots showing up 6 to 13 days after immunization. One woman died, and one is in critical condition. The agencies will investigate whether the issue is more widespread, but for now at least, those who suffered a poor reaction represent a miniscule percentage of the near 7 million Americans who have received the shot. The government's decision immediately set off a debate about the wisdom of halting a vaccine's usage over what appears to be such a rare reaction. In a joint statement , the FDA and CDC said that "Right now, these adverse events appear to be extremely rare," but that "We are recommending a pause in the use of this vaccine out of an abundance of caution." In its own statement, Johnson & Johnson said, "At present, no clear causal relationship has been established between these rare events and… Read full this story
- What is sepsis? Signs and symptoms of the infection explained
- What Are Selenium Supplements?
- And now for my next tripe
- 28 Devastating Infectious Diseases
- The Emergency-Room Nurse Who Always Has to Know Who’s the Sickest Person in the Room
- Two MPs go into 'self-isolation' after attending Westminster bus conference attended by coronavirus patient and 250 other delegates
- Michael Nnamdi: “For A Tormented Nation and A Besieged Faith”
U.S. to Pause J&J Vaccine Rollout After Rare Blood-Clot Reaction have 272 words, post on nymag.com at April 13, 2021. This is cached page on wBird. If you want remove this page, please contact us.